Rhinostics
- Company typePrivate
- Founded2020
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Rhinostics firmographics
Firmographics- Name
- Rhinostics
- Website
- https://rhinostics.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Rhinostics industry classification
Industry- Product category
- Diagnostic specimen collection devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Nasal Drug Delivery Devices (Sprays/Powder Devices) (HLAHAIAK)
- akta.pro secondary industry
- Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK)
Keywords
Where Rhinostics is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Markets served
Rhinostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Sample Collection Device Sales: Sale of automated nasal swab devices and other sample collection technologies to laboratories and healthcare facilities
Go-to-market motion1 record
Rhinostics product offering
Product offeringCore offering
Rhinostics manufactures automated sample collection devices for clinical and diagnostic laboratory use. Its flagship product is a proprietary automated nasal swab intended to streamline specimen collection workflows, and the company is developing blood collection device technologies for diagnostic specimen collection.
Product overview
Rhinostics offers a portfolio of automated sample collection devices for diagnostic applications. The core product is an automated nasal swab system designed to standardize and streamline specimen collection. The company is expanding its product line to include blood collection devices, positioning itself as a provider of comprehensive sample collection solutions for laboratory and clinical settings.
Differentiator
Problem solved
Functional benefit
Products and services
- Automated Nasal Swab
Companies that use Rhinostics
Customer profileSegments1 record
Ideal customer profiles1 record
Rhinostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Rhinostics partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
Rhinostics competitors and assessment
Company assessmentEmerging players
- Tasso: Manufacturer of Tasso OnDemand, a capillary blood microsampling device for decentralized sample collection. Comparable to Rhinostics' planned blood collection extension in the at-home and clinical capillary sampling category.
- Yourbio Health: Maker of the TAP II device for virtually painless capillary blood collection. Comparable to Rhinostics on the automated specimen collection mechanism and decentralized clinical sampling positioning.
- Seventh Sense Biosystems: Developer of the TAP device for push-button capillary blood collection. Competes in the same emerging minimally-invasive sample collection space as Rhinostics' blood collection roadmap.
- Velano Vascular: Developer of needle-free blood collection technology for hospital settings. Directly comparable to Rhinostics' blood-collection device extension — both pursue less-invasive specimen collection adjacent to traditional venipuncture.
- Neoteryx (Trajan Scientific): Manufacturer of the Mitra microsampling device for volumetric absorptive microsampling. Comparable to Rhinostics in alternative sample collection formats targeting clinical and remote testing workflows.
Broad incumbents
- OraSure Technologies: Specialist in oral fluid and other non-invasive sample collection devices for diagnostics. Comparable to Rhinostics in the alternative specimen collection category for clinical and at-home testing.
- Becton, Dickinson and Company (BD): Global medical device incumbent with a large diagnostic specimen collection and microbiology portfolio (BD ESwab, BD MAX). Competes broadly with Rhinostics in clinical lab sample collection consumables.
Direct peers
- Puritan Medical Products: Major U.S. manufacturer of single-use specimen collection swabs, including nasopharyngeal and nasal swabs used in clinical diagnostics. Closest direct competitor to Rhinostics' core product line.
- Copan Diagnostics: Established manufacturer of flocked swabs and automated sample-collection/pre-analytical systems (e.g., WASP, WASPLab). Directly comparable to Rhinostics in the automated nasal swab and laboratory accessioning workflow category.
Regional players
- Hardy Diagnostics: U.S.-based manufacturer and distributor of microbiology specimen collection and transport devices serving clinical laboratories. Directly comparable to Rhinostics on specimen collection consumables sold into clinical labs.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Rhinostics social profiles
Digital presenceRhinostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rhinostics leadership team
Management profileNumber of profiles
Profiles5 records
Rhinostics funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rhinostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rhinostics
What does Rhinostics do?
Rhinostics manufactures automated sample collection devices for clinical and diagnostic laboratory use. Its flagship product is a proprietary automated nasal swab intended to streamline specimen collection workflows, and the company is developing blood collection device technologies for diagnostic specimen collection.
Is Rhinostics a public or private company?
Rhinostics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Rhinostics founded?
Rhinostics was founded in 2020. It employs 1 to 10 people.
Where is Rhinostics based?
Rhinostics is headquartered in Boston, United States, in the North America region.
How does Rhinostics make money?
One revenue line is on record: sample Collection Device Sales.
Who are Rhinostics's main competitors?
Emerging players on record are Tasso, Yourbio Health, Seventh Sense Biosystems, Velano Vascular and Neoteryx (Trajan Scientific). Broad incumbents are OraSure Technologies and Becton, Dickinson and Company (BD). Direct peers are Puritan Medical Products and Copan Diagnostics. Hardy Diagnostics is listed as a regional player.
Does Rhinostics have an API?
No public API is recorded for Rhinostics.
What industry is Rhinostics in?
Rhinostics's product category is Diagnostic specimen collection devices. Its primary akta.pro industry code is HLAHAIAK, Nasal Drug Delivery Devices (Sprays/Powder Devices), with a secondary code of HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits). Its NAICS code is 339113 and its SIC code is 3841.